BSF Enterprise PLC Stock Price, News & Analysis
Company Description
BSF Enterprise PLC is a London-based biotechnology company focused on cell-based tissue engineering and related biotechnological applications. The company is associated with the LSE ticker BSFA and the OTCQB symbol BSFAF. Its business centers on technologies that use engineered cells, culture media, and tissue engineering methods to support products and materials across cultivated meat, lab-grown leather, human corneas, collagen growth, and skin substitutes.
The company owns 100% of 3D Bio-Tissues, or 3DBT, a tissue-engineering business with patent-protected intellectual property. 3DBT is the operating platform named in company materials for BSF's work in cell-based tissue engineering. Its activities include human cornea production, cultivated-meat development, and commercial products that support cell-culture processes used in cellular agriculture and life-science applications.
A central 3DBT product is City-Mix, a patented non-toxic culture media supplement described by the company as a cell booster. City-Mix is formulated to facilitate macromolecular crowding, a process used to improve cell-culture conditions. The product is positioned for cultivated meat and cellular agriculture, where media efficiency, replacement of animal-derived serum, and reduction of scaffold or filler requirements are part of the company’s stated product rationale. BSF also identifies biopharmaceutical applications for City-Mix, including work connected to gene therapy, stem cells, regenerative medicine, life-science companies, and academic research.
BSF’s broader technology focus extends beyond one product category. Company materials describe a platform strategy built around tissue templating for corneas, meat, and leather, with commercialization through intellectual-property development and licensing to manufacturers, wholesalers, and distributors. The company has also described merger and acquisition activity as part of its growth strategy for acquiring complementary technologies within tissue engineering.
The company’s application areas place BSF at the intersection of biotechnology, cellular agriculture, regenerative medicine, and alternative materials. Its work in cultivated meat is tied to cell-based production methods, while its lab-grown leather activities are tied to engineered biological materials rather than animal hides. Its medical and life-science applications include human corneas, collagen growth, and skin substitutes, reflecting the same underlying tissue-engineering approach applied to different end markets.
Stock Performance
BSF Enterprise PLC (BSFAF) stock last traded at $0.0160. Over the past 12 months, the stock has lost 72.6%. At a market capitalization of $2.7M, BSFAF is classified as a micro-cap stock with approximately 166.9M shares outstanding.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in BSF Enterprise PLC (BSFAF) currently stands at 166.0 thousand shares, down 63.1% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 3220%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BSF Enterprise PLC (BSFAF) currently stands at 1.0 days, down 35.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 83.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BSFAF Company Profile & Sector Positioning
BSF Enterprise PLC (BSFAF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BSFAF often look at related companies in the same sector, including ASEP MED HLDGS INC (SEPSF), Core One Labs (CLABF), Kane Biotech Inc (KNBIF), Tron Group (TGRP), and Orgenesis Inc (ORGS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BSFAF's relative position within its industry.